Healthcare Services

Increasing Adoption Of Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive Drug Delivery Systems Outsourcing Market Is Influencing The Gastroretentive Drug Delivery Systems Outsourcing Market

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Gastroretentive Drug Delivery Systems Outsourcing Market Become By 2030 Compared To 2026?

The market size for gastroretentive drug delivery systems outsourcing has experienced substantial growth recently. This market is expected to expand from $1.49 billion in 2025 to $1.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. Historically, this market expansion can be linked to factors such as the constraints of traditional oral drug delivery, the rise in CRO services, the requirement for enhanced drug absorption, the broadening of pharmaceutical pipelines, and advances in formulation technology.

The gastroretentive drug delivery systems outsourcing market is poised for significant expansion in the coming years, with its size expected to reach $2.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is attributable to several factors, including the increasing complexity of drug molecules, a rising demand for patient-centric delivery systems, the expansion of outsourcing strategies, continued innovation in gastroretentive technologies, and pharmaceutical companies’ focus on cost optimization. Major trends shaping the forecast period include the increasing outsourcing of advanced drug delivery development, a heightened demand for formulations providing prolonged gastrointestinal retention, the growing adoption of floating drug delivery systems, the expansion of contract research organization (CRO) partnerships in formulation development, and a concentrated effort on enhancing drug bioavailability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

What Primary Factors Are Fueling The Expansion Of The Gastroretentive Drug Delivery Systems Outsourcing Market?

The expanding occurrence of gastrointestinal disorders is projected to fuel the advancement of the gastroretentive drug delivery systems outsourcing market in the future. Gastrointestinal disorders encompass a broad spectrum of ailments impacting the digestive tract, including the stomach, liver, gallbladder, intestines, and pancreas. The rise in these disorders is attributable to aging populations, antibiotic usage, infectious agents, shifts in diet, stress and lifestyle factors, and obesity. By outsourcing gastroretentive drug delivery systems, pharmaceutical firms gain access to the necessary resources and specialized knowledge to manage the increasing burden of gastrointestinal disorders, thereby enhancing patient outcomes and overall quality of life. For illustration, in August 2023, the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based government‑funded research institute and public health agency, indicated that 60 to 70 million people were affected by all digestive diseases. Consequently, the growing prevalence of gastrointestinal disorders is propelling the gastroretentive drug delivery systems outsourcing market. The escalating incidence of age-related disorders is anticipated to stimulate the growth of the gastroretentive drug delivery systems outsourcing market moving forward. Age-related disorders describe a wide array of medical conditions and functional impairments that predominantly affect older adults, encompassing cardiovascular diseases, neurodegenerative disorders, musculoskeletal conditions, and sensory impairments. The increase in these disorders is linked to aging populations, extended life expectancy, lifestyle factors, and the accumulation of chronic diseases. For example, in April 2025, the Centers for Disease Control and Prevention, a US-based government public health agency, reported that in 2023, approximately 194 million American adults, including 6 in 10 young adults, 8 in 10 midlife adults, and 9 in 10 older adults, had at least one condition. The prevalence of chronic conditions saw an increase of 7.0 percentage points among young adults. Therefore, the rising prevalence of age-related disorders is driving the gastroretentive drug delivery systems outsourcing market.

How Is The Gastroretentive Drug Delivery Systems Outsourcing Market Examined Through Segment Analysis?

The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –

1) By Type: Floating Systems, Bioadhesive Systems, Other Types

2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Floating Systems: Single Unit Systems, Multiple Unit Systems

2) By Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers

3) By Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems

Which Trends Are Affecting The Gastroretentive Drug Delivery Systems Outsourcing Market Framework?

Key companies operating within the gastroretentive drug delivery systems outsourcing market are prioritizing the development of innovative offerings, such as ready-to-fill (RTF) colon functional capsules, to improve both drug delivery efficiency and patient convenience. Ready-to-fill (RTF) colon functional capsules are defined as pre-manufactured, empty capsules designed to be filled with specific formulations or active ingredients targeted for the colon. As an illustration, in September 2024, Evonik, a Germany-based advanced drug delivery provider, unveiled EUDRACAP colon functional capsules, which are specifically engineered for the targeted delivery of oral drugs to the ileo-colonic region. These novel capsules represent the first ready-to-fill option available in the market, aiming to deliver sensitive active ingredients, including live biotherapeutic products (LBPs). Currently offered in technical grade, a GMP-grade product is also undergoing development. EUDRACAP colon significantly enhances the oral drug development process by simplifying formulation and accelerating time to market, signifying a major advancement in gastroretentive drug delivery systems.

Who Are The Leading Firms Participating In The Gastroretentive Drug Delivery Systems Outsourcing Market?

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, Evonik Industries AG, SGS SA, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

Access The Complete Gastroretentive Drug Delivery Systems Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

Which Regional Market Leads The Gastroretentive Drug Delivery Systems Outsourcing Market?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gastroretentive Drug Delivery Systems Outsourcing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp

Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2026, By The Business Research Company

Gastroparesis Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

Diabetic Gastroparesis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report

Gastric Volvulus Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795